Pre-Revenue WEED, INC. Narrows Q1 Net Loss to $(175K), Still Faces Funding Challenges
BUDZ sits 96% above its 52-week low of $0.016 on light trading volume (0.3× avg).
Summary
WEED, INC. reported its first-quarter 2026 results, showing no revenue and a net loss of $(175,256), or $(0.001) per share. This update follows the company's recent 10-K filing, which highlighted a going concern opinion, significant losses, and critically low cash reserves. While the company remains pre-revenue and unprofitable, the reported net loss represents a substantial improvement from $(440,455) in the prior-year quarter, indicating some progress in cost control or operational efficiency. For a micro-cap company facing severe financial challenges, these results provide an updated view of its burn rate. Investors will need to monitor any developments in revenue generation from its hemp product plans, progress in genomic studies, or successful funding initiatives, as the company's commercial outlook explicitly states plans are "pending funding."
At the time of this announcement, BUDZ was trading at $0.03 on OTC in the Life Sciences sector, with a market capitalization of approximately $4.6M. The 52-week trading range was $0.02 to $0.08. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.